Integrated BioPharma (INBP) Free Cash Flow by Year
Integrated BioPharma Inc generated $895K in free cash flow in fiscal year 2026. This represents a decrease of 52.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Integrated BioPharma Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
INBP Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
INBP Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Integrated BioPharma Inc financials
Frequently Asked Questions
Integrated BioPharma Inc generated $895K in free cash flow in fiscal year 2026.
Integrated BioPharma Inc (INBP) free cash flow fell by 52.2% year over year, from $1.9M to $895K in fiscal year 2026.
Across the 15 fiscal years this page covers, Integrated BioPharma Inc (INBP) free cash flow went from -$926K in fiscal year 2012 to $895K in fiscal year 2026.
Integrated BioPharma Inc (INBP) reported -$1.3M in free cash flow in Q4 2026.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Integrated BioPharma Inc (INBP) reported on that line in every period on record.